Expert Opinion on Biological Therapy, Volume 22, Issue 12 (2022)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Biological Therapy, Volume 22, Issue 12 (2022)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Volume 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Biological therapies for psoriasis

Foreword

Editorial
Biologics for psoriasis: is there any unmet need left?
Steven R Feldman & M Alan Menter
Page: 1429
Published online: 16 Dec 2022
CitationforBiologics for psoriasis: is there any unmet need left? | Full Text | PDF (119.8 KB) | EPUB
  • 1183 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Editorial

Editorial
New frontiers in personalized medicine in psoriasis
Elisa Camela, Luca Potestio, Gabriella Fabbrocini, Angelo Ruggiero & Matteo Megna
Pages: 1431-1433
Published online: 16 Aug 2022
First Page PreviewforNew frontiers in personalized medicine in psoriasis | Full Text | References | PDF (155 KB) | EPUB
  • 2071 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Paradoxical reactions to biologicals for psoriasis
Elisa Camela, Luca Potestio, Gabriella Fabbrocini & Matteo Megna
Pages: 1435-1437
Published online: 05 Dec 2022
First Page PreviewforParadoxical reactions to biologicals for psoriasis | Full Text | References | PDF (170.2 KB) | EPUB
  • 2252 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Psoriatic arthritis improved on risankizumab: does the presence of psoriatic arthritis mean a drug approved for psoriatic arthritis has to be prescribed?
Rohan Singh, Alexandria M Brown, Warren H Chan, Morgan A Farr, Sid Venkataraman & Steven R Feldman
Pages: 1439-1441
Published online: 13 Jun 2022
First Page PreviewforPsoriatic arthritis improved on risankizumab: does the presence of psoriatic arthritis mean a drug approved for psoriatic arthritis has to be prescribed? | Full Text | References | PDF (152.6 KB) | EPUB
  • 1321 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Special Report

Article
Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndrome
Emanuele Trovato, Pietro Rubegni & Francesca Prignano
Pages: 1443-1448
Published online: 26 Jun 2022
AbstractforPlace in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndrome | Full Text | References | PDF (196.4 KB) | EPUB
  • 719 Views
  • 3 CrossRef citations
  • 0Altmetric

Review

Review
Biologic insights from single-cell studies of psoriasis and psoriatic arthritis
Joy Q Jin, David Wu, Riley Spencer, Kareem G Elhage, Jared Liu, Mitchell Davis, Marwa Hakimi, Sugandh Kumar, Zhi-Ming Huang, Tina Bhutani & Wilson Liao
Pages: 1449-1461
Published online: 09 Nov 2022
AbstractforBiologic insights from single-cell studies of psoriasis and psoriatic arthritis | Full Text | References | PDF (408.3 KB) | EPUB
  • 809 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Pathogenesis-oriented therapy of psoriasis using biologics
Wolf-Henning Boehncke & Nicolò Costantino Brembilla
Pages: 1463-1473
Published online: 20 Jul 2022
AbstractforPathogenesis-oriented therapy of psoriasis using biologics | Full Text | References | PDF (1.1 MB) | EPUB
  • 433 Views
  • 3 CrossRef citations
  • 0Altmetric
Review
Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive review
Elia Rosi, Maria Thais Fastame, Antonella Di Cesare & Francesca Prignano
Pages: 1475-1487
Published online: 25 Aug 2022
AbstractforTargeting IL-17A for the treatment of pustular psoriasis: a comprehensive review | Full Text | References | PDF (323.6 KB) | EPUB
  • 310 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Anti-IL 23 biologics for the treatment of plaque psoriasis
Alan Vu, Caden Ulschmid & Kenneth B. Gordon
Pages: 1489-1502
Published online: 27 Oct 2022
AbstractforAnti-IL 23 biologics for the treatment of plaque psoriasis | Full Text | References | PDF (379.1 KB) | EPUB
  • 527 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Treating psoriasis in the elderly: biologics and small molecules
Matteo Megna, Luca Potestio, Gabriella Fabbrocini & Elisa Camela
Pages: 1503-1520
Published online: 14 Jun 2022
AbstractforTreating psoriasis in the elderly: biologics and small molecules | Full Text | References | PDF (469.7 KB) | EPUB
  • 424 Views
  • 24 CrossRef citations
  • 0Altmetric
Review
Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis
Paolo Gisondi, Davide Geat, Francesco Bellinato & Giampiero Girolomoni
Pages: 1521-1529
Published online: 08 Aug 2022
AbstractforUse of biologics during the COVID-19 pandemic: lessons learned from psoriasis | Full Text | References | PDF (268.1 KB) | EPUB
  • 203 Views
  • 4 CrossRef citations
  • 0Altmetric
Review
Biological treatment for erythrodermic psoriasis
Sunil Dogra & Hitaishi Mehta
Pages: 1531-1543
Published online: 28 Sep 2022
AbstractforBiological treatment for erythrodermic psoriasis | Full Text | References | PDF (327.8 KB) | EPUB
  • 379 Views
  • 2 CrossRef citations
  • 0Altmetric
Review
What’s new and what’s next for biological and targeted synthetic treatments in psoriatic arthritis?
Flavia Sunzini, Arianna D’Antonio, Mauro Fatica, Paola Triggianese, Paola Conigliaro, Elisabetta Greco, Alberto Bergamini & Maria Sole Chimenti
Pages: 1545-1559
Published online: 05 Dec 2022
AbstractforWhat’s new and what’s next for biological and targeted synthetic treatments in psoriatic arthritis? | Full Text | References | PDF (692 KB) | EPUB
  • 1864 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Guselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experience
Federico Bardazzi, Filippo Viviani, Yuri Merli, Vito Di Lernia, Francesca Peccerillo, Andrea Conti, Claudia Lasagni, Michela Tabanelli, Simone D’Adamio, Sergio Di Nuzzo, Chiara Cortellazzi & Federica Filippi
Pages: 1561-1566
Published online: 13 Apr 2022
AbstractforGuselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experience | Full Text | References | PDF (2.7 MB) | EPUB
  • 370 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Biologic treatment of psoriasis in oncologic patients
Lluís Rusiñol, Gemma Camiña-Conforto & Luis Puig
Pages: 1567-1578
Published online: 16 Dec 2022
AbstractforBiologic treatment of psoriasis in oncologic patients | Full Text | References | PDF (340.7 KB) | EPUB
  • 551 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis
Paolo Gisondi, Davide Geat, Patrizio Armeni, Francesco Bellinato, Martina Maurelli & Giampiero Girolomoni
Pages: 1579-1584
Published online: 26 Apr 2022
AbstractforCost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis | Full Text | References | PDF (515.6 KB) | EPUB | Supplemental
  • 171 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, Andrea Chiricozzi, Clara De Simone, Claudio Bonifati, Pierluigi Bruni, Federico Diotallevi, Maria Esposito, Dario Graceffa, Katharina Hansel, Francesco Loconsole, Gaia Moretta, Cristina Mugheddu, Manuela Papini, Antonio Richetta, Nevena Skroza, Laura Atzori, Maria Concetta Fargnoli, Severino Persechino, Annamaria Offidani, Luca Stingeni, Ketty Peris, Concetta Potenza & Luca Bianchi
Pages: 1585-1592
Published online: 22 Jun 2022
AbstractforReal-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year | Full Text | References | PDF (836.3 KB) | EPUB | Supplemental
  • 357 Views
  • 1 CrossRef citations
  • 0Altmetric

Correction

Correction
Correction
Pages: i-iv
Published online: 05 Dec 2022
First Page PreviewforCorrection | Full Text | PDF (144.1 KB) | EPUB
  • 230 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Review of emerging biological therapies for recurrent and advanced metastatic cervical cancer
Virginia E. Fontenot et al.
Editorial | Published online: 25 Jun 2024
Free Access
Treatment options for advanced hepatocellular carcinoma: the potential of biologics
Federico Rossari et al.
Review Article | Published online: 24 Jun 2024
Checkpoint inhibition for early-stage hormone receptor-positive breast cancer
Ilana Schlam et al.
Review Article | Published online: 24 Jun 2024
Targeting gut and intratumoral microbiota: a novel strategy to improve therapy resistance in cancer with a focus on urologic tumors
Bingquan Wu et al.
Review Article | Published online: 24 Jun 2024
View all latest articles